Cystatin-C has been cited as an emerging risk marker for CVD [32] , but is again only of borderline significance for this outcome in the present report.
← all excerpts
Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS).
2
—
—
The sentences
Troponin and BNP each show a strong trend with risk of CVD death which is not shown with risk of death from non-CVD causes.